about
Discovery, Synthesis, and Structure–Activity Relationship of a Series of N -Aryl-bicyclo[2.2.1]heptane-2-carboxamides: Characterization of ML213 as a Novel KCNQ2 and KCNQ4 Potassium Channel OpenerTherapeutic Strategies for Neuropathic Pain: Potential Application of Pharmacosynthetics and OptogeneticsThe development of chronic pain: physiological CHANGE necessitates a multidisciplinary approach to treatmentN-Pyridyl and Pyrimidine Benzamides as KCNQ2/Q3 Potassium Channel Openers for the Treatment of EpilepsyPolarized axonal surface expression of neuronal KCNQ potassium channels is regulated by calmodulin interaction with KCNQ2 subunit.Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration.Activation of vascular KCNQ (Kv7) potassium channels reverses spasmogen-induced constrictor responses in rat basilar artery.Modulation of K(v)7 potassium channels by a novel opener pyrazolo[1,5-a]pyrimidin-7(4H)-one compound QO-58Vascular KCNQ potassium channels as novel targets for the control of mesenteric artery constriction by vasopressin, based on studies in single cells, pressurized arteries, and in vivo measurements of mesenteric vascular resistance.K+ channel modulators for the treatment of neurological disorders and autoimmune diseasesVoltage-gated potassium channels as therapeutic targets.Cinnamamide Derivatives for Central and Peripheral Nervous System Disorders--A Review of Structure-Activity Relationships.M-type K(+) channels in peripheral nociceptive pathways.Oxidation potentials of N-modified derivatives of the analgesic flupirtine linked to potassium KV 7 channel opening activity but not hepatocyte toxicity.The pan-Kv7 (KCNQ) Channel Opener Retigabine Inhibits Striatal Excitability by Direct Action on Striatal Neurons In Vivo.Enhancing m currents: a way out for neuropathic pain?Synthesis and Evaluation of Potent KCNQ2/3-Specific Channel Activators.
P2860
Q24634116-FA64204B-1DA8-423C-A723-D859D7845C18Q26765373-8D09B23F-0B18-410F-B3CB-48E2089DAE7FQ26860844-4B4397A9-85D8-4178-B9C7-3A265120E51CQ30040856-D5547C20-38B2-4758-A6A7-C9FF370E18F5Q33982175-8EA1CA4C-178B-4717-B46A-3A98C1099110Q34390785-73B64E94-32D7-4835-AF1D-DE46EC3E82B9Q35216454-52D85478-C96B-4A60-AFE4-EC2860ACA25DQ36781082-E070CD38-B5D6-4556-9C58-5B924B896E5DQ37001792-8098D67F-2590-4F3A-857E-0371AC373721Q37162392-7DB726AA-69EC-443C-B921-EF8DCF122590Q37464784-BDFD7206-0598-4457-AB25-D7826E1E6626Q38530238-72049D2B-B989-4AC7-995E-5124C3391C6CQ38628600-7BE70701-5F3B-49B8-BD94-763F9E2D8C3CQ38940792-4F7E57DC-330B-4B1E-B4DF-EFC6ECEAE469Q39632547-7BD76EDC-C8E4-449A-90D1-008BBB059B4AQ43071251-317C7A31-7E7E-4B5D-9F46-8DB32B717DEDQ51738570-45BCC926-3B5E-4EA1-9DBB-72BFD9D1A3E6
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Kv7 (KCNQ) channel modulators and neuropathic pain.
@ast
Kv7 (KCNQ) channel modulators and neuropathic pain.
@en
type
label
Kv7 (KCNQ) channel modulators and neuropathic pain.
@ast
Kv7 (KCNQ) channel modulators and neuropathic pain.
@en
prefLabel
Kv7 (KCNQ) channel modulators and neuropathic pain.
@ast
Kv7 (KCNQ) channel modulators and neuropathic pain.
@en
P356
P1476
Kv7 (KCNQ) channel modulators and neuropathic pain.
@en
P2093
Gordon Munro
William Dalby-Brown
P304
P356
10.1021/JM060989L
P407
P577
2007-05-10T00:00:00Z